Plain-English translation of NCT06410352 on ClinicalTrials.gov ↗ · Source last updated ·
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing three different approaches to help people with metabolic syndrome (a cluster of conditions including high blood sugar, high blood pressure, and excess weight) lose weight and live longer. You would be randomly assigned to one of three groups: taking semaglutide (a medication that helps control appetite) plus another blood sugar medication, undergoing weight loss surgery, or following a very strict low-calorie diet. Researchers want to see which approach works best for improving health outcomes over time.
Metabolic syndrome affects millions of people and increases the risk of heart disease, stroke, and diabetes complications. While several treatment options exist, doctors don't yet know which approach—medication, surgery, or diet—gives patients the best long-term results for living longer and staying healthier.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to one of three groups: medication (weekly injections plus a daily pill), surgery (a laparoscopic weight loss procedure with pre-operative testing), or a very strict diet program. You'll have regular appointments over about 6 months where your weight, blood sugar, blood pressure, and other health markers will be measured. The researchers will follow your progress and track how well each approach works for you.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Kazakhstan